
Belite Bio is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases with significant unmet medical needs. Built on our proprietary Retinol Binding Protein 4 (RBP4) IP portfolio, our clinical pipeline includes Tinlarebant (LBS-008), an oral therapy currently in late-stage clinical trials (including the Phase 3 DRAGON and PHOENIX studies) for Stargardt disease (STGD1) and Geographic Atrophy (GA) in dry AMD.
At Belite Bio, we are dedicated to developing innovative solutions to treat untreatable conditions and prevent vision loss in patients worldwide. As an early-stage company, we value entrepreneurial thinking, collaboration, accountability and the ability to thrive in fast moving environments.
Belite MSLs will play a central role in supporting the launch activities of the company’s first potential US commercial product in inherited retinal diseases (IRDs). MSLs will support the advancement of clinical and research programs by delivering expert clinical, scientific, and technical education to the Ophthalmology community in their assigned region. Through their scientific exchange, these roles will be responsible for cultivating and maintaining long-term collaborative peer-to-peer relationships with thought leaders, practices, payers and other stakeholders specializing in ophthalmic care. These individuals need to be passionate about communicating deep scientific knowledge as part of a collaborative medical affairs team.
as a Belite scientific resource to HCPs, payers and formulary decision makers
Competencies
Behavioral Traits
Belite Bio provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state, or local laws.
Belite Bio is committed to working with and providing reasonable accommodation to individuals with disabilities. If you need reasonable accommodation for any part of the application or interviewing process due to a medical condition or disability, please contact human resources to let us know the nature of your request.
Pay Range: $165,000 – $240,000 USD (Salary offered will depend on candidate location, market rate adjustments, skills, and relevant experience).
Belite Bio provides a competitive total compensation package that includes base salary, annual incentive bonuses, equity participation, and a full benefit package (health, dental, vision, 401(k), and paid time off).

Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.